B-hADGRE5 mice

C57BL/6-Adgre5tm1(ADGRE5)Bcgen/Bcgen • 112968

B-hADAMTS5 mice
B-hADGRG2 mice

B-hADGRE5 mice

Product nameB-hADGRE5 mice
Catalog number112968
Strain nameC57BL/6-Adgre5tm1(ADGRE5)Bcgen/Bcgen
Strain backgroundC57BL/6
NCBI gene ID976
AliasesCD97, TM7LN1

on this page

  • Description
  • Targeting strategy
  • Phenotypic analysis
  • Physiological data

Posters

View All

    Publication

      Related Products

      View All
      Description
      • CD97 mediates cell adhesion, migration, and stimulates angiogenesis by binding to CD55, integrin α5β1 and other ligands.
      • B-hADGRE5 is used to evaluate the efficacy or safety of antitumor drugs lung cancer.
      Targeting strategy

      Gene targeting strategy for B-hADGRE5 mice. In humanized mice, exons 2-7 of mouse Adgre5 are replaced by exons 2-18 of the human ADGRE5. The 5’UTR and signal peptide of the mouse gene are retained, while the 3’UTR is human. The ADGRE5 expression is driven by endogenous mouse Adgre5 promoter, while mouse Adgre5 gene transcription and translation will be disrupted.

      mRNA expression analysis

      Strain specific analysis of ADGRE5 mRNA expression in wild-type C57BL/6 mice and B-hADGRE5 mice by RT-PCR. Spleen RNA were isolated from wild-type C57BL/6 mice (+/+) and homozygous B-hADGRE5 mice (H/H), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human ADGRE5 primers. Mouse Adgre5 mRNA was only detectable in wild-type mice. Human ADGRE5 mRNA was exclusively detectable in homozygous B-hADGRE5 mice but not in wild-type mice.

      Protein expression analysis in spleen and blood-T cells

      Strain specific ADGRE5 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hADGRE5 mice by flow cytometry. Splenocytes(top) and blood cells (bottom) were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hADGRE5 mice (H/H) (female, 10-week-old, n=1). Protein expression was analyzed with anti-human ADGRE5 antibody (Biolegend, 336307) by flow cytometry. Human ADGRE5 was exclusively detectable in homozygous B-hADGRE5 mice, but not in wild-type C57BL/6 mice.

      Protein expression analysis in spleen and blood-B cells

      Strain specific ADGRE5 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hADGRE5 mice by flow cytometry. Splenocytes(top) and blood cells (bottom) were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hADGRE5 mice (H/H) (female, 10-week-old, n=1). Protein expression was analyzed with anti-human ADGRE5 antibody (Biolegend, 336307) by flow cytometry. Human ADGRE5 was exclusively detectable in homozygous B-hADGRE5 mice, but not in wild-type C57BL/6 mice.

      Protein expression analysis in spleen and blood-NK cells

      Strain specific ADGRE5 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hADGRE5 mice by flow cytometry. Splenocytes(top) and blood cells (bottom) were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hADGRE5 mice (H/H) (female, 10-week-old, n=1). Protein expression was analyzed with anti-human ADGRE5 antibody (Biolegend, 336307) by flow cytometry. Human ADGRE5 was exclusively detectable in homozygous B-hADGRE5 mice, but not in wild-type C57BL/6 mice.

      Protein expression analysis in spleen and blood-DC cells

      Strain specific ADGRE5 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hADGRE5 mice by flow cytometry. Splenocytes(top) and blood cells (bottom) were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hADGRE5 mice (H/H) (female, 10-week-old, n=1). Protein expression was analyzed with anti-human ADGRE5 antibody (Biolegend, 336307) by flow cytometry. Human ADGRE5 was exclusively detectable in homozygous B-hADGRE5 mice, but not in wild-type C57BL/6 mice.

      Protein expression analysis in spleen and blood-Monocytes

      Strain specific ADGRE5 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hADGRE5 mice by flow cytometry. Splenocytes(top) and blood cells (bottom) were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hADGRE5 mice (H/H) (female, 10-week-old, n=1). Protein expression was analyzed with anti-human ADGRE5 antibody (Biolegend, 336307) by flow cytometry. Human ADGRE5 was exclusively detectable in homozygous B-hADGRE5 mice, but not in wild-type C57BL/6 mice.

      Protein expression analysis in spleen and blood-Macrophages

      Strain specific ADGRE5 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hADGRE5 mice by flow cytometry. Splenocytes(top) and blood cells (bottom) were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hADGRE5 mice (H/H) (female, 10-week-old, n=1). Protein expression was analyzed with anti-human ADGRE5 antibody (Biolegend, 336307) by flow cytometry. Human ADGRE5 was exclusively detectable in homozygous B-hADGRE5 mice, but not in wild-type C57BL/6 mice.

      Protein expression analysis in spleen and blood-Neutrophils

      Strain specific ADGRE5 expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hADGRE5 mice by flow cytometry. Splenocytes(top) and blood cells (bottom) were collected from wild-type C57BL/6 mice (+/+) and homozygous B-hADGRE5 mice (H/H) (female, 10-week-old, n=1). Protein expression was analyzed with anti-human ADGRE5 antibody (Biolegend, 336307) by flow cytometry. Human ADGRE5 was exclusively detectable in homozygous B-hADGRE5 mice, but not in wild-type C57BL/6 mice.

      Frequency of leukocyte subpopulations in spleen

      Frequency of leukocyte subpopulations in spleen by flow cytometry. Splenocytes were isolated from wild-type C57BL/6 mice (female, n=3, 6-week-old) and homozygous B-hADGRE5 mice (female, n=3, 6-week-old). A. Flow cytometry analysis of the splenocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequency of T cell subpopulations. Percentages of T cells, B cells, NK cells, dendritic cells, neutrophils, monocytes, macrophages, CD4+ T cells, CD8+ T cells and Tregs in B-hADGRE5 mice were similar to those in C57BL/6 mice. Values are expressed as mean ± SEM. Significance was determined by two-way ANOVA test. *P < 0.05, **P < 0.01, ***p < 0.001.

      Frequency of leukocyte subpopulations in blood

      Frequency of leukocyte subpopulations in blood by flow cytometry. Blood cells were isolated from wild-type C57BL/6 mice (female, n=3, 6-week-old) and homozygous B-hADGRE5 mice (female, n=3, 6-week-old). A. Flow cytometry analysis of the blood cells was performed to assess the frequency of leukocyte subpopulations. B. Frequency of T cell subpopulations. Percentages of T cells, B cells, NK cells, dendritic cells, neutrophils, monocytes, macrophages, CD4+ T cells, CD8+ T cells and Tregs in B-hADGRE5 mice were similar to those in C57BL/6 mice. Values are expressed as mean ± SEM. Significance was determined by two-way ANOVA test. *P < 0.05, **P < 0.01, ***p < 0.001.

      Frequency of leukocyte subpopulations in lymph nodes

      Frequency of leukocyte subpopulations in lymph nodes by flow cytometry. Lymph nodes cells were isolated from wild-type C57BL/6 mice (female, n=3, 6-week-old) and homozygous B-hADGRE5 mice (female, n=3, 6-week-old). A. Flow cytometry analysis of the lymph nodes cells was performed to assess the frequency of leukocyte subpopulations. B. Frequency of T cell subpopulations. Percentages of T cells, B cells, NK cells, CD4+ T cells, CD8+ T cells and Tregs in B-hADGRE5 mice were similar to those in C57BL/6 mice. Values are expressed as mean ± SEM. Significance was determined by two-way ANOVA test. *P < 0.05, **P < 0.01, ***p < 0.001.